US Patent Issued to GIVAUDAN on March 24 for "Enzyme-mediated process for making Amberketal and Amberketal homologues" (Swiss Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,153, issued on March 24, was assigned to GIVAUDAN SA (Vernier, Switzerland).

"Enzyme-mediated process for making Amberketal and Amberketal homologues" was invented by Eric Eichhorn (Zurich, Switzerland), Felix Flachsmann (Duebendorf, Switzerland) and Andreas Goeke (Duebendorf, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "An enzyme-mediated method for the production of Amberketal and Amberketal homologues, the products of said method, and uses of said products."

The patent was filed on April 14, 2021, under Application No. 17/995,512.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/...